These Analysts Boost Their Forecasts On Ocular Therapeutix After Q4 Results - Ocular Therapeutix (NASDAQ:OCUL)
Ocular Therapeutix, Inc. (NASDAQ: OCUL) reported worse-than-expected fourth-quarter financial results on Monday.
Stay updated with breaking news from Jonathan Wolleben. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ocular Therapeutix, Inc. (NASDAQ: OCUL) reported worse-than-expected fourth-quarter financial results on Monday.
U.S. stocks were lower, with the Dow Jones index dipping more than 500 points on Tuesday.
Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued soft first-quarter guidance.
Shares of IPG Photonics Corporation (NASDAQ:IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter fin...
Investors are contemplating where and when the next big obesity drug deal will occur.